Hi guys, Welcome to the Advanced Video Search Engine, and you are watching Cancer immunotherapy | The PD-L1 pathway. That video is uploaded by Roche at 2016-05-26T00:53:20-07:00. We are promoting this video only for entertainment and educational purpose only. So, I hope you like & enjoy it. [SNLr2hqJlrY]
| Name | Cancer immunotherapy | The PD-L1 pathway |
| Video Uploader | Video From Roche |
| Upload Date | This Video Uploaded At 26-05-2016 07:53:20 |
| Video Discription | The role of the immune system is to protect the body from foreign invaders. In responding to cancer, T cells play a central role in the immune system. Programmed death ligand 1 (PD-L1) is one of the inhibitory ligands that, under normal conditions, help maintain immune homeostasis. In many cancers, however, PD-L1 can help tumour cells evade immune system surveillance. To learn more about Roche’s commitment to cancer immunotherapy, visit http://www.roche.com/cancer-immunotherapy. To learn more about our cancer immunotherapy research, visit http://global.researchcancerimmunotherapy.com/. Subscribe to our YouTube channel now: https://www.youtube.com/user/roche?sub_confirmation=1 Get in touch with us: https://www.roche.com/ https://www.facebook.com/RocheCareers https://www.linkedin.com/company/roche https://twitter.com/roche Roche has been committed to improving lives since the company was founded in 1896 in Basel, Switzerland. Today, Roche creates innovative medicines and diagnostic tests that help millions of patients globally. Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience. For more information and insights visit: https://www.roche.com/ SNLr2hqJlrY |
| Category | Science & Technology |
| Tags | cancer immunotherapy | immune system | immune response to cancer | programmed death ligand 1 | PD-L1 | PD-L1 expression | tumour microenvironment | T cell | Roche | immuno-oncology | IO | cancer research | tumour-infiltrating immune cells | dendritic cells | lymph nodes | macrophages | natural killer cells | lymphocytes | immune homeostasis | cytotoxic activity | PD-1 | B7.1 | tumour cells | immunity | oncology | pharmaceutical | biopharma | health | bladder cancer | t cells and b cells |
